Literature DB >> 7540563

Sequence homologies between nucleotide binding regions of CFTR and G-proteins suggest structural and functional similarities.

P Manavalan1, D G Dearborn, J M McPherson, A E Smith.   

Abstract

Sequence homology between the alpha-subunits of G-proteins and other GTP-binding proteins and certain regions within the nucleotide binding domains (NBDs) of cystic fibrosis transmembrane conductance regulator (CFTR) indicates that these protein structures may be similar. A sequence alignment of the NBDs of CFTR and NBDs from other membrane transporters, forms the basis of a structural model. This model predicts that one of the conserved sequences GGQR, within which a number of CF mutations occur, forms part of the nucleotide binding pocket and serves as an ON/OFF conformational switch as observed in GTP binding proteins. Furthermore, based on subtle sequence differences between the first and second NBDs of CFTR and from structure-activity data, we suggest that the nucleotide binding site environments of the two NBDs are different.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540563     DOI: 10.1016/0014-5793(95)00463-j

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.

Authors:  C Randak; E A Auerswald; I Assfalg-Machleidt; W W Reenstra; W Machleidt
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel.

Authors:  R Schreiber; A Hopf; M Mall; R Greger; K Kunzelmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 3.  ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart.

Authors:  Alexey E Alekseev; Denice M Hodgson; Amy B Karger; Sungjo Park; Leonid V Zingman; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-04-14       Impact factor: 5.000

4.  Cystic fibrosis transmembrane conductance regulator activation stimulates endosome fusion in vivo.

Authors:  J Biwersi; N Emans; A S Verkman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 5.  Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

Review 6.  Mitochondrial ABC transporters function: the role of ABCB10 (ABC-me) as a novel player in cellular handling of reactive oxygen species.

Authors:  Marc Liesa; Wei Qiu; Orian S Shirihai
Journal:  Biochim Biophys Acta       Date:  2012-08-03

7.  Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide-binding domains.

Authors:  Allan C Powe; Layla Al-Nakkash; Min Li; Tzyh-Chang Hwang
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

8.  A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: comparison of wild-type and delta F508 mutant forms.

Authors:  I Yike; J Ye; Y Zhang; P Manavalan; T A Gerken; D G Dearborn
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

9.  Domain interactions in the yeast ATP binding cassette transporter Ycf1p: intragenic suppressor analysis of mutations in the nucleotide binding domains.

Authors:  J M Falcón-Pérez; M Martínez-Burgos; J Molano; M J Mazón; P Eraso
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

10.  Vanadate-catalyzed photocleavage of the signature motif of an ATP-binding cassette (ABC) transporter.

Authors:  Erin E Fetsch; Amy L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.